The Institute of Health Sciences (formerly the Health Science Center) was jointly established in 1999 by Shanghai Institutes for Biological Sciences (SIBS) of Chinese Academy of Sciences (CAS) and Shanghai Jiao Tong University School of Medicine (SJTUSM, formerly Shanghai Second Medical University). The Health Science Center began its formal operations in April 2002 and was renamed as the Institute of Health Sciences (IHS) on November 9, 2005. The institute undertakes the challenges in the frontiers of biomedical research and responds to the demands of social development. By relying upon the leading position of SIBS in basic biological research and the superior clinical expertise of SJTUSM, IHS focuses on basic and applied research of major human diseases, with a special emphasis on the development of clinical applications.
Translational medical research is the core of our mission and is a unique strength of our institute. Focusing on three key research directions including stem cell, immunology and tumor, IHS has basic researchers and clinical scientists working side-by-side to build highly collaborative translational research programs. We are also building up our expertise in stem cell-related drug discovery and development, disease metabolomics, personalized cancer therapy, immune microenvironment and chronic diseases, and myocardial repair. Currently, IHS has 348 members working in 27 research groups, administration and facility management. Our principal investigators include 1 Academician of Chinese Academy of Sciences, 2 Academicians of Chinese Academy of Engineering, 2 members of National “1000 Talents”, 6 Chief Scientists of Major State Basic Research Development Program of Chinese Ministry of Science and Technology, and 4 National “1000 Young Talents”. Aiming at promoting translational biomedical research, the Institute of Health Sciences has formed alliance with 12 hospitals affiliated with Soochow University School of Medicine, which allows IHS to act as a bridge between basic research and clinical medicine to promote dialogues between clinical demand and biological research.
With the emphasis of Chinese government on the improvement of population health and our already diverse research enterprise, IHS will seize all possible opportunities to strengthen innovation, accelerate the translational research, and train outstanding scientists to meet the needs of health challenges in our nation and throughout the world.